Algorhythm Holdings, Inc.RIMEEarnings & Financial Report
Algorhythm Holdings, Inc. is a technology firm that develops AI-powered clinical decision support solutions for the healthcare industry. It primarily caters to healthcare providers across North America, with tools aimed at improving patient care quality, streamlining clinical workflows, and cutting operational costs for medical institutions.
RIME Q4 FY2025 Key Financial Metrics
Revenue
$-2.1M
Gross Profit
$-2.4M
Operating Profit
$-2.8M
Net Profit
$-3.5M
Gross Margin
117.3%
Operating Margin
135.4%
Net Margin
169.1%
YoY Growth
56.1%
EPS
$-0.36
Algorhythm Holdings, Inc. Q4 FY2025 Financial Summary
Algorhythm Holdings, Inc. reported revenue of $-2.1M (up 56.1% YoY) for Q4 FY2025, with a net profit of $-3.5M (up 78.2% YoY) (169.1% margin). Cost of goods sold was $356.0K, operating expenses totaled $373.0K.
Key Financial Metrics
| Total Revenue | $-2.1M |
|---|---|
| Net Profit | $-3.5M |
| Gross Margin | 117.3% |
| Operating Margin | 135.4% |
| Report Period | Q4 FY2025 |
Algorhythm Holdings, Inc. Quarterly Revenue & Net Profit History
Algorhythm Holdings, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $-2.1M | +56.1% | $-3.5M | 169.1% |
| Q2 FY2025 | $2.7M | +11.3% | $-809.0K | -29.8% |
| Q4 FY2024 | $-4.7M | — | $-16.0M | 340.0% |
| Q2 FY2024 | $2.4M | -7.0% | $-6.1M | -250.8% |
| Q1 FY2024 | $2.4M | — | $-2.4M | -97.6% |
| Q3 FY2023 | $15.9M | -6.9% | $97.5K | 0.6% |
| Q2 FY2023 | $2.6M | -77.5% | $-2.5M | -93.7% |
| Q4 FY2022 | $7.1M | -66.5% | $-1.9M | -27.2% |
Income Statement
| Q4 2022 | Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q4 2024 | Q2 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.1M | $2.6M | $15.9M | $2.4M | $2.4M | $-4.7M | $2.7M | $-2.1M |
| YoY Growth | -66.5% | -77.5% | -6.9% | N/A | -7.0% | N/A | 11.3% | 56.1% |
Balance Sheet
| Q4 2022 | Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q4 2024 | Q2 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $24.2M | $15.0M | $32.6M | $19.9M | $12.4M | $18.3M | $12.7M | $12.7M |
| Liabilities | $11.0M | $5.5M | $22.9M | $14.7M | $13.2M | $28.8M | $9.9M | $14.6M |
| Equity | $13.2M | $9.5M | $9.7M | $5.2M | $-872000 | $-10.5M | $2.8M | $-1.9M |
Cash Flow
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q4 2024 | Q2 2025 | |
|---|---|---|---|---|---|---|
| Operating CF | $-2.5M | $1.4M | $-2.6M | $-2.9M | $-1.5M | $-2.3M |